Fortis Healthcare Q1 FY27 Results: Net Profit Declines to ₹477.8 Crore
Fortis Healthcare reported Q1 FY27 results with total income at ₹5,083.7 crore. Net profit declined to ₹477.8 crore from ₹518.8 crore year-on-year. Diluted EPS was ₹0.63. The company also appointed B S R & Co. LLP as Tax Auditors for FY26.
The decline in net profit and EPS, along with the appointment of new tax auditors, are material information for investors, warranting a medium impact assessment.
The net profit has declined compared to the previous year, which is a negative indicator. However, the company has appointed new tax auditors and the overall financial performance, while showing a dip, is not drastically negative.
Fortis Healthcare Limited announced its un-audited financial results for the quarter ended June 30, 2026. The company reported a total income of ₹5,083.7 crore (₹50,837 lacs) for the quarter, compared to ₹4,730.4 crore (₹47,304 lacs) in the same period last year. Expenses for the quarter stood at ₹4,623.6 crore (₹46,236 lacs).
The net profit for the quarter from continuing operations after tax was ₹477.8 crore (₹4,778 lacs), a decrease from ₹518.8 crore (₹5,188 lacs) in the corresponding quarter of the previous year. The company also reported an exceptional gain of ₹133 crore (₹1,330 lacs) for the quarter ended June 30, 2026.
Earnings per share (EPS) on a diluted basis for continuing operations were ₹0.63 for the quarter ended June 30, 2026, down from ₹0.69 in the prior year's quarter. EBITDA for the quarter was ₹1,228.5 crore (₹12,285 lacs).
Additionally, the Board of Directors approved the appointment of M/s. B S R & Co. LLP as the Tax Auditors for the Financial Year 2025-26. The Board meeting commenced at 12:00 Noon IST and concluded at 6:45 PM IST on August 06, 2026.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.